Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;18(9):3602-3611.
doi: 10.1016/j.sapharm.2022.02.003. Epub 2022 Feb 9.

Exploring factors of uneven use of telehealth among outpatient pharmacy clinics during COVID-19: A multi-method study

Emma E Thomas  1 , Soraia de Camargo Catapan  2 , Helen M Haydon  3 , Michael Barras  4 , Centaine Snoswell  5
Affiliations

Exploring factors of uneven use of telehealth among outpatient pharmacy clinics during COVID-19: A multi-method study

Emma E Thomas et al. Res Social Adm Pharm. 2022 Sep.

Abstract

Background: To enable services to be provided at a distance during the COVID-19 pandemic, outpatient pharmacy services in Australia underwent near-immediate reform by moving to telehealth, including telephone and video consults.

Objective: To investigate how telehealth was used in a metropolitan outpatient pharmacy setting before and after the start of the COVID-19 restrictions and the various influences on the uptake of phone and video modalities.

Methods: A multi-methods approach was used including: (1) quantifying administrative activity data between July 2019 to December 2020 and, (2) semi-structured interviews with key stakeholders (n = 34).

Results: Activity data: Between July 2019 to December 2020 16,377 outpatient pharmacy consults were provided. Of these, 13,543 (83%) were provided in-person, 2,608 (16%) by telephone and 226 (1.4%) by video consult. COVID-19 impacted how these services were provided with telephone activity more than four-times higher in April 2020 than March 2020 and slight increases in video consults. Pharmacists have heavily favoured using the telephone despite the recommendation that video consults be used as the primary mode of contact and that telephone only be used when a video consult was not possible. As soon as COVID-19 restrictions eased, clinicians gradually returned to in-person appointments, maintaining some use of telephone and very limited use of video consult. Semi-structured interviews: Whilst clinicians recognised the potential benefits of video consults, challenges to routine use included the additional administrative and planning work required pre-consult, perceptions that patients were unable to use the technology, and the belief that in-person care was 'better' and that the telephone was easier.

Conclusion: Organisational strategies that encouraged the use of video over telephone (e.g. through financial incentives) did not appear to influence clinicians' choice of care modality. Implementation studies are required to co-develop solutions to embed telehealth options into outpatient pharmacy settings that provide the best experience for both patients and clinicians.

Keywords: COVID-19; Outpatient pharmacist; Telehealth; Videoconferencing.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Monthly outpatient pharmacist service consults by modality from June 2019 to December 2020.
Fig. 2
Fig. 2
Overall themes and categories identified from the semi-structured interviews.
Fig. 3
Fig. 3
Benefits and challenges of phone vs. video consults.
See this image and copyright information in PMC

References

    1. Hume A.L., Pharm D., Kirwin J., et al. Improving care transitions : current practice and future American college of clinical pharmacy. Pharmacotherapy. 2012;32(11):326–337. - PubMed
    1. Tong E.Y., Roman C.P., Mitra B., et al. Reducing medication errors in hospital discharge summaries: a randomised controlled trial. Med J Aust. 2017;206(1):36–39. doi: 10.5694/mja16.00628. - DOI - PubMed
    1. Wheeler A.J., Scahill S., Hopcroft D., Stapleton H. Reducing medication errors at transitions of care is everyone's business. Aust Prescr. 2018;41(3):73–77. doi: 10.18773/austprescr.2018.021. - DOI - PMC - PubMed
    1. Hawes E.M., Maxwell W.D., White S.F., Mangun J., Lin F.C. Impact of an outpatient pharmacist intervention on medication discrepancies and health care resource utilization in posthospitalization care transitions. J Prim Care Commun Heal. 2014;5(1):14–18. doi: 10.1177/2150131913502489. - DOI - PubMed
    1. Al-Qudah Msc R.A., Al-Badriyeh D., Al-Ali F.M., Altawalbeh S.M., Basheti I.A. Cost-benefit analysis of clinical pharmacist intervention in preventing adverse drug events in the general chronic diseases outpatients. J Eval Clin Pract. 2020;26:115–124. doi: 10.1111/jep.13209. - DOI - PubMed

Publication types